STRATEGIC INQUIRIES

Corporate Development & Strategic Review

RejuvaTech LLC is evaluating qualified strategic acquisition, licensing, co-development, manufacturing, and platform-commercialization inquiries regarding its filed non-provisional IP portfolio covering next-generation NAD+ precursor technologies, BioPeak® advanced absorption systems, and premium longevity product platforms.

Technical packages, patent summaries, formulation details, freedom-to-operate materials, and supporting data are available only under NDA.

Qualified corporate inquiries may use the form below. Please include your company name, title, corporate email address, area of interest, and whether you are requesting NDA-protected review materials.